Quantum News
Sign InSign Up
Back to News
research

Thursday 3/26 Insider Buying Report: RPC, TPST

BNK Invest
Loading...
2 min read
0 likes
⚡ Quantum Brief
Two corporate insiders made significant stock purchases this week, signaling potential confidence in their companies’ futures. RPC Director David M. McCoy bought 70,000 shares at $7.37 each, totaling $515,900. RPC stock rose 3.1% on Thursday following McCoy’s Monday purchase, suggesting investor optimism. The SEC filing confirms the transaction, reinforcing insider buying as a bullish indicator for the company’s outlook. Tempest Therapeutics CEO Matthew Angel acquired 231,482 shares at $2.16 each, spending $500,001. Despite his purchase, TPST shares fell 4.6% Thursday, trading as low as $1.65—23.8% below his buy-in price. The disparity between Angel’s purchase price and current TPST valuation presents a rare discount for investors. Analysts note such gaps often precede volatility or potential rebounds in biotech stocks. Both transactions underscore insider buying as a key market sentiment driver, with RPC outperforming TPST post-purchase. The moves reflect differing sector dynamics—energy services versus biopharma.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (23).png
Quantum News · Media Library

Understand this faster with AI

ChatGPTAsk ChatGPTPerplexityResearch with PerplexityClaudeExplain with ClaudeGrokDiscuss on Grok

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Markets RPC Thursday 3/26 Insider Buying Report: RPC, TPST March 26, 2026 — 01:44 pm EDT Written by BNK Invest for BNK Invest-> As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

At Ridgepost Capital, a filing with the SEC revealed that on Monday, Director David M. McCoy purchased 70,000 shares of RPC, at a cost of $7.37 each, for a total investment of $515,900. Ridgepost Capital is trading up about 3.1% on the day Thursday. And on Tuesday, CEO and President Matthew Angel bought $500,001 worth of Tempest Therapeutics, buying 231,482 shares at a cost of $2.16 each. Tempest Therapeutics is trading down about 4.6% on the day Thursday. Investors can bag TPST at a price even lower than Angel did, with shares trading as low as $1.65 in trading on Thursday which is 23.8% under Angel's purchase price. VIDEO: Thursday 3/26 Insider Buying Report: RPC, TPST The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags MarketsStocks BNK Invest BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally. 10 Bargains You Can Buy Cheaper Than Insiders Did-> 10 Stocks Crossing Below Book Value-> 10 Oversold Stocks You Need To Know About-> More articles by this source-> Stocks mentioned RPC TPST More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Read Original

Source Information

Source: Nasdaq

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.